Pleasanton, CA, United States of America

Sarah E B Taylor

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: 10X Genomics, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sarah E B Taylor

Introduction

Sarah E B Taylor is an accomplished inventor based in Pleasanton, CA (US). She has made significant contributions to the field of biotechnology, particularly in the detection of T cell interactions. Her work has implications for immunology and therapeutic development.

Latest Patents

Sarah E B Taylor holds 1 patent titled "Methods for detecting binding of peptide-MHC monomers to T cells." This patent features devices, systems, and methods for detecting the binding of polynucleotide-peptide conjugate-major histocompatibility complex (pMHC) monomers to T cell receptors (TCR) on T cells. The patent also discusses the use of a peptide library to detect the binding of antigenic peptides in a pMHC monomer to a T cell receptor.

Career Highlights

Sarah is currently employed at 10X Genomics, Inc., where she continues to innovate in the field of genomics and immunology. Her expertise in peptide-MHC interactions has positioned her as a key figure in advancing research in this area.

Collaborations

Throughout her career, Sarah has collaborated with notable colleagues, including Michael John Terry Stubbington and Katherine Pfeiffer. These collaborations have further enriched her research and contributed to the advancement of their shared goals in biotechnology.

Conclusion

Sarah E B Taylor's work exemplifies the impact of innovative research in biotechnology. Her contributions to the understanding of T cell interactions are paving the way for future advancements in immunotherapy and related fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…